Study Confirms SKY92 Test Improves Multiple Myeloma Risk Assessment

Study Confirms SKY92 Test Improves Multiple Myeloma Risk Assessment

By Daniella Parra A new study published in the British Journal of Haematology confirms that the SKY92 gene expression profiling test significantly enhances risk stratification in multiple myeloma patients, outperforming traditional clinical markers, SkylineDx said. Risk stratification by SKY92 showed...

Boca Paddle by CityPickle Breaks Ground June 10

Boca Paddle by CityPickle Breaks Ground June 10

By Karen Roman Boca Paddle by CityPickle said its groundbreaking ceremony took place on June 10 in a 100,000-square-foot facility hosting Boca Raton’s first climate-controlled indoor pickleball and paddle facility. The event included opening remarks by the city’s Mayor Scott...

Beacon Therapeutics Appoints Chief Medical Officer

Beacon Therapeutics Appoints Chief Medical Officer

By Karen Roman Biotech company Beacon Therapeutics Holdings Ltd announced the designation of Dr. Daniel Chung as its new Chief Medical Officer. Dr. Chung has three decades of experience in clinical ophthalmology and academic research, and he formerly served as...

Nanox AI Bone Solution Receives CE Mark Certification

Nanox AI Bone Solution Receives CE Mark Certification

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said its AI bone solution HealthOST has received CE mark certification which enables its commercialization across Europe. HealthOST examines CT scans to assess vertebral height loss and bone mineral density and helps...

Input your search keywords and press Enter.